New Objet Eden260V Dental Advantage 3D Printer Produces Highly Accurate Dental and Orthodontic Models, as well as Surgical Guides
3D Printer debuts at the LMT Lab Day Show in Chicago Feb. 21 - 22
MINNEAPOLIS & REHOVOT, Israel — (BUSINESS WIRE) — February 21, 2014 — Stratasys Ltd. (Nasdaq: SSYS), a manufacturer of 3D printers and materials for personal use, prototyping and production, today introduced the Objet Eden260V Dental Advantage 3D Printer, which is easy-to-use and offers affordable access to digital dentistry. The 3D printer will be on display Feb. 21 - 22 at the LMT Lab Day Show in Chicago, in booth 203.
The Objet Eden260V Dental Advantage 3D Printer offers dental and orthodontic labs affordable access to advanced digital dentistry (Photo: Stratasys)
For dental labs seeking faster treatment and an enhanced profit model, the Objet Eden260V Dental Advantage 3D Printer produces surgical guides and dental models in-house directly from intraoral scanner output. Similarly, orthodontic labs may reduce costs by 3D printing accurate and smooth models for orthodontic appliances, which can help them increase their competitive edge.
The new 3D printer features a custom-tailored materials package and a build tray that is 20 to 40 percent larger than that of alternatives for the dental sector. This allows users to improve workflow and optimize productivity by printing more models in a single build. The 3D printer also features printing speeds up to 33 percent faster than other dental 3D printing products.
Based on Stratasys’ successful Eden platform, the Objet Eden260V Dental Advantage 3D Printer harnesses Stratasys’ pedigree of innovation to enable production of ultra-high resolution 3D models. These benefits are enhanced by the 3D printer’s small copier-sized footprint, which makes it ideal for convenient and unobtrusive operation in any lab or dental practice.
“Stratasys continues to make digital dentistry happen and is fully committed to this market,” said Avi Cohen, Director of Global Dental at Stratasys. “The Objet Eden260V Dental Advantage 3D printer is a cost-effective solution package that is designed to increase productivity and turnaround times while delivering precision prototypes and production parts.”
The Objet Eden260V Dental Advantage 3D Printer Offers:
- Professional grade technology
- Consistent, accurate results
- Easy-to-use operation with fast turnaround times
- Clean, safe materials
- Small, copier-size footprint with quiet operation
More information about the Objet Eden260V Dental Advantage is available on the Stratasys website at Objet Eden260V Dental Advantage.
Media Resources available at the Stratasys Newsroom include:
- High resolution images
- White papers
- Machine specifications sheet
- Materials specifications sheet
- Case study on dental material
Stratasys Ltd. (Nasdaq: SSYS), headquartered in Minneapolis, Minn. and Rehovot, Israel, manufactures 3D printers and materials for prototyping and production. The company’s patented FDM® and PolyJetTM 3D Printing technologies produce prototypes and manufactured goods directly from 3D CAD files or other 3D content. Systems include 3D printers for idea development, prototyping and direct digital manufacturing. Stratasys subsidiaries include MakerBot and Solidscape, and the company operates the RedEye digital-manufacturing service. Stratasys has more than 1700 employees, holds over 500 granted or pending additive manufacturing patents globally, and has received more than 20 awards for its technology and leadership. Online at: www.stratasys.com or http://blog.stratasys.com
Objet and Stratasys are registered trademarks and Eden, PolyJet and DentalAdvantage are trademarks of Stratasys Ltd. and or its subsidiaries or affiliates.
Cautionary Statement Regarding Forward-Looking Statements
Certain information included or incorporated by reference in this press may be deemed to be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are often characterized by the use of forward-looking terminology such as “may,” “will,” “expect,” “anticipate,” “estimate,” “continue,” “believe,” “should,” “intend,” “project” or other similar words, but are not the only way these statements are identified. These forward-looking statements may include, but are not limited to, statements relating to the company’s objectives, plans and strategies, statements regarding the company’s products and their expected performance, statements that contain projections of results of operations or of financial condition (including, with respect to the MakerBot merger) and all statements (other than statements of historical facts) that address activities, events or developments that the company intends, expects, projects, believes or anticipates will or may occur in the future. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. The company has based these forward-looking statements on assumptions and assessments made by its management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Important factors that could cause actual results, developments and business decisions to differ materially from those anticipated in these forward-looking statements include, among other things: the company’s ability to efficiently and successfully integrate the operations of Stratasys, Inc. and Objet Ltd. after their merger as well as the ability to successfully integrate MakerBot into Stratasys; the overall global economic environment; the impact of competition and new technologies; general market, political and economic conditions in the countries in which the company operates; projected capital expenditures and liquidity; changes in the company’s strategy; government regulations and approvals; changes in customers’ budgeting priorities; litigation and regulatory proceedings; and those factors referred to under “Risk Factors”, “Information on the Company”, “Operating and Financial Review and Prospects”, and generally in the company’s annual report on Form 20-F for the year ended December 31, 2012 filed with the U.S. Securities and Exchange Commission and in other reports that the Company has filed with the SEC. Readers are urged to carefully review and consider the various disclosures made in the company’s SEC reports, which are designed to advise interested parties of the risks and factors that may affect its business, financial condition, results of operations and prospects. Any forward-looking statements in this press release are made as of the date hereof, and the company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.